首页> 外文期刊>Carbohydrate research >First derivatives of myo-inositol 1,4,6-trisphosphate modified at positions 2 and 3:structural analogues of D-myo-inositol myo-inositol 1,4,5-trisphosphate
【24h】

First derivatives of myo-inositol 1,4,6-trisphosphate modified at positions 2 and 3:structural analogues of D-myo-inositol myo-inositol 1,4,5-trisphosphate

机译:肌肉肌醇1,4,6-三磷酸的一阶衍生物在位置2和3:3修饰的D-肌醇肌醇1,4,5-三磷酸的结构类似物

获取原文
获取原文并翻译 | 示例
           

摘要

Novel,structurally modified potential mimics of the second messenger D-myo-inositol 1,4,5-trisphosphate,based on the biologically active regioisomer D-myo-inositol 1,4,6-trisphosphate,were synthesised.DL-5-O-Benzyl-1,4,6-tri-O-p-methoxybenzyl-myo-inositol was the key intermediate for the preparation of the following compounds:DL-3-deoxy-,DL-3-deoxy-2-O-methyl-,DL-3-(2-hydroxyethyl)-,DL-3-(3-hydroxyethyl)-and DL-3-(4-hydroxyethyl)-myo-inositol 1,4,6-trisphosphate.DL-1,4,6-Tri-O-allyl-5-O-benzyl-myo-inositol was used to prepare DL-2-O-methyl-myo-inositol 1,4,6-trisphosphate.Deoxy-compounds were prepared by reduction of the corresponding tosylated intermediate sing Super Hydride.The hydroxyalkyl groups were introduced at the C-3 of myo-inositol using the corresponding benzyl protected hydroxy alkyl bromide via the cis-2,3-O-dibutylstannylene acetal.Methylation and benzylation at C-2 was accomplished using methyl iodide and benzyl bromide,respectively,in the presence of sodium hydride.Deblocking of p-methoxybenzyl groups was accomplished with TFA in dichloromethane ad the allyl groups were removed by isomerisation to the cis-prop-1-enyl derivative,which was hydrolysed under acidic conditions to give the corresponding 1,4,6-triol.The 1,4,6-triols were phosphitylated with the P(III)reagent bis(benzyloxy)(diisopropylamino)phosphine in the presence of 1H-tetrazole then oxidised with 3-chloroperoxybenzoic acid followed by deblocking by hydrogenolysis to give DL-2-O-methyl,DL-3-deoxy-,DL-3-deoxy-2-O-methyl-,DL-3-(2-hydroxyethyl)-,DL-3-(3-hydroxyethyl)-and DL-3-(4-hydroxyethyl)-myo-inositol 1,4,6-trisphosphate,respectively.
机译:合成了基于生物活性区域异构体D-肌醇1,4,6-三磷酸的第二种信使D-肌醇1,4,5-三磷酸的新型,结构修饰的潜在模拟物.DL-5-O -苄基-1,4,6-三-Op-甲氧基苄基-肌醇是制备以下化合物的关键中间体:DL-3-deoxy-,DL-3-deoxy-2-O-methyl-, DL-3-(2-羟乙基)-,DL-3-(3-羟乙基)-和DL-3-(4-羟乙基)-肌醇1,4,6-三磷酸.DL-1,4,6用-Tri-O-烯丙基-5-O-苄基-肌醇制备DL-2-O-甲基-肌醇1,4,6-三磷酸酯。通过还原相应的甲苯磺酸酯制备脱氧化合物。使用相应的苄基保护的羟烷基溴化物通过顺式2,3-O-二丁基锡亚锡缩醛将羟烷基引入到肌醇的C-3处,在C-2处进行甲基化和苄基化反应。分别在氢化钠存在下的甲基碘和苄基溴。用TFA在二氯甲烷中完成对甲氧基苄基的对接反应,然后将烯丙基异构化为顺-丙-1-烯基衍生物,然后将其在酸性条件下水解,得到相应的1,4,6-三醇。在1H-四唑存在下,用P(III)试剂双(苄氧基)(二异丙氨基氨基)膦将1,4,6-三醇磷酸化,然后用3-氯过氧苯甲酸氧化,然后通过氢解解封,得到DL-2-O -甲基,DL-3-脱氧-,DL-3-脱氧-2-O-甲基-,DL-3-(2-羟乙基)-,DL-3-(3-羟乙基)-和DL-3-( (4-羟乙基)-肌醇1,4,6-三磷酸。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号